References & further readingSelank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) analogue of the endogenous immunomodulatory tetrapeptide tuftsin, extended with a C-terminal Pro-Gly-Pro sequence for metabolic stability. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and is registered in the Russian Federation only; it is not licensed by the MHRA, EMA or FDA.
Regulatory & compliance notice
This product is supplied strictly for in-vitro laboratory research. It is not a licensed medicine in the United Kingdom, is not approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency for human or veterinary use, and is not intended to diagnose, treat, cure or prevent any disease. Nothing on this page constitutes medical advice.
External links point to primary literature or regulatory records and open in a new tab. Citations are provided so the reader can independently verify every factual claim made on this page. Last reviewed 22 July 2026.